Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inderjit Jabbal-Gill

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|November 5, 2010
Nasal vaccine innovationInderjit Jabbal-Gill
The Journal of Pharmacy and Pharmacology|June 23, 2005
Effect of chitosan on the intranasal absorption of salmon calcitonin in sheepMichael Hinchcliffe, Inderjit Jabbal-Gill, Alan Smith
Expert Opinion on Drug Delivery|June 20, 2012
Chitosan-based delivery systems for mucosal vaccinesInderjit Jabbal-Gill, Peter Watts, Alan Smith
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2005
Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulationsYu-Hui Cheng, A Margaret Dyer, Inderjit Jabbal-Gill, et al.
Influenza and Other Respiratory Viruses|July 14, 2011
The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccineSigne C Svindland, Åsne Jul-Larsen, Rishi Pathirana, et al.
Vaccine|May 27, 2005
Effective nasal influenza vaccine delivery using chitosanRobert C Read, Simone C Naylor, Christopher W Potter, et al.
Vaccine|May 27, 2004
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosanEdel A McNeela, Inderjit Jabbal-Gill, Lisbeth Illum, et al.
Influenza and Other Respiratory Viruses|November 23, 2012
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccineSigne C Svindland, Gabriel K Pedersen, Rishi D Pathirana, et al.
Infection and Immunity|January 24, 2003
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin aKingston H G Mills, Catherine Cosgrove, Edel A McNeela, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|November 5, 2010
Nasal vaccine innovationInderjit Jabbal-Gill
The Journal of Pharmacy and Pharmacology|June 23, 2005
Effect of chitosan on the intranasal absorption of salmon calcitonin in sheepMichael Hinchcliffe, Inderjit Jabbal-Gill, Alan Smith
Expert Opinion on Drug Delivery|June 20, 2012
Chitosan-based delivery systems for mucosal vaccinesInderjit Jabbal-Gill, Peter Watts, Alan Smith
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 23, 2005
Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulationsYu-Hui Cheng, A Margaret Dyer, Inderjit Jabbal-Gill, et al.
Influenza and Other Respiratory Viruses|July 14, 2011
The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccineSigne C Svindland, Åsne Jul-Larsen, Rishi Pathirana, et al.
Vaccine|May 27, 2005
Effective nasal influenza vaccine delivery using chitosanRobert C Read, Simone C Naylor, Christopher W Potter, et al.
Vaccine|May 27, 2004
Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosanEdel A McNeela, Inderjit Jabbal-Gill, Lisbeth Illum, et al.
Influenza and Other Respiratory Viruses|November 23, 2012
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccineSigne C Svindland, Gabriel K Pedersen, Rishi D Pathirana, et al.
Infection and Immunity|January 24, 2003
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin aKingston H G Mills, Catherine Cosgrove, Edel A McNeela, et al.
Pageof 1